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 1 
Abstract 
 
 Dsk1 is the Schizosaccharomyces pombe functional homolog of human SRPK1, 
an SR protein kinase that regulates localization and function of SR protein splicing 
factors involved in transcription, alternative splicing, and mRNA export. It has been 
shown that a Dsk1 deletion strain of S. pombe is sensitive to exposure to butylated 
hydroxyanisole (BHA), a phenol derivative commonly used as a food preservative. Little 
is known about how BHA interacts with cells on a functional level, although it has been 
shown to be cytotoxic and tumorigenic. The aims of this thesis are to study the effect of 
BHA on eukaryotic cells and the possible involvement of Dsk1 protein kinase in the 
cellular response network to BHA through the use of fluorescence microscopy. The 
results showed that in BHA-treated cells, Dsk1 exhibits reduced nuclear localization and 
increased incidence of cytoplasmic clusters as well as a series of changes in cellular 
morphology. These observations imply that the function of Dsk1 is altered in response to 
BHA, consistent with genomic data collected by the Tang Lab. Thus, this study provides 
a basis for a series of future studies that will reveal in more detail how BHA affects 
fission yeast cells, and potentially gene or protein functional homologs in human cells. 
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Introduction 
Schizosaccharomyces pombe as a model organism 
 Schizosaccharomyces pombe, also known as fission yeast, is a useful model 
organism for the study of essential cellular processes, despite the fact that humans and 
yeast diverged from each other approximately one billion years ago. The fission yeast 
genome, sequenced in 2002, consists of three linear chromosomes, with approximately 
5,100 protein-coding genes (Wood, et al. 2012). Although impressive, these numbers are 
dwarfed by the 23 chromosomes and 25,000 protein-coding genes found in human nuclei 
(Lander et al., 2001). At a glance, it may seem that fission yeast and humans do not have 
much in common at all. In truth, however, when it comes to core cellular processes, 
fission yeast has proved an indispensable tool for the study of cell biology. 
Fission yeast is an ideal organism for study of the cell cycle and essential cellular 
mechanisms because it is well characterized, relatively simple, easy to grow, and 
maintains functional homology of many genes with higher eukaryotes. It also has introns 
and exons, which can be argued to make it more similar to higher eukaryotes than 
budding yeast (Tang et al., 1998). In the modern era of fission yeast research, databases 
like PomBase allow researchers to access up-to-date information about fission yeast 
genes, proteins, and current publications (Wood, et al, 2012). The cell cycle of fission 
yeast is very well understood, and many mutants exist that we can use to manipulate the 
progression of the cell throughout the cell cycle. In contrast with human tissue cultures, 
fission yeast are much easier and cheaper to grow and maintain. In addition to all of these 
things—and the crux of what makes fission yeast so valuable as a model organism—
essential cellular processes are extremely well conserved. The likelihood that a mutation 
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in the most crucial genes would allow survival is so low that these genes have evolved 
very little over time. Thus, even though so many other genes have evolved as humans 
have, those genes that control crucial cellular processes stay profoundly similar. So 
highly conserved are these major genes among eukaryotes, that if one is deleted in fission 
yeast, it can often be functionally replaced by the human homolog of that gene (Lee and 
Nurse, 1987). 
Paul Nurse demonstrated the power of this concept when he applied a cross-
species complementation assay to fission yeast. Using the cdc2ts mutant strain, he 
systematically transfected an entire human cDNA library into fission yeast. The strain he 
used had a temperature sensitive mutation in cdc2, a protein he had shown was required 
for the fission yeast to progress through the cell cycle. What he found was that despite all 
the differences between fission yeast and humans, there was indeed a human gene that 
could replace the function of mutant cdc2 at the restrictive temperature (Lee and Nurse, 
1987). At the time, this gene was called CDC2Hs, but now it is known as Cdk1. Paul 
Nurse and his colleagues had not only presented the answer to one of the major questions 
still at hand during the time, but also demonstrated that fission yeast maintain a 
compelling level of genetic homology. The fact that this quality can be found in a 
relatively simple, well-characterized organism allows researchers to study cellular 
mechanisms at a basic level before moving on to more complex eukaryotes. 
 
Genome-wide sensitivity assays 
In a field like genomics, studying human cells offers vast pools of information to 
wade through, and often it is hard to tell where to start. However, because many genes 
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are well conserved between fission yeast and humans, preliminary studies in fission yeast 
can offer a catalog of genes of interest for more targeted research. For example, genomic 
comparison has produced a catalog of 289 disease-related genes that humans share with 
fission yeast. Genes associated with cancer make up the largest subset of those 289 genes 
(Wood et al., 2002). This makes sense, considering that cell cycle genes are among those 
most profoundly conserved between humans and fission yeast, and cancer is a cell cycle 
disorder.   
Another strategy that is often employed using fission yeast is genome-wide 
sensitivity assays. These assays use deletion libraries to determine how different genes 
respond to a certain compound. If a given deletion is found to be sensitive to a 
compound, it can be inferred that the gene may be required for the proper response to 
damage or stress induced by the compound. In contrast, if a deletion is found to be 
resistant, possible explanations include gene involvement in an arrest pathway response, 
or inhibition of arrest factors triggered by the presence of the compound. These assays, 
while not meant to do much else other than identify possible targets for further study, are 
ideal applications of fission yeast as a model organism. 
 
Butylated hydroxyanisole (BHA) and its effect on cells 
 Many synthetic antioxidants are used in foods as preservatives. One of the most 
common of these is butylated hydroxyanisole, or BHA. This chemical, classified as a 
phenol-derivative, helps preserve foods by inhibiting lipid peroxidation (Kahl, 1984). In 
addition to this effect, BHA has been shown to help cells defend against acute radiation 
and chemical toxicity (Yu et al., 2000). Despite its documented benefits, BHA has also 
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been shown in multiple studies to promote cancer formation in the forestomachs of 
multiple mammalian species (Ito et al., 1983; Nera et al., 1988). Analysis of the 
carcinogenic qualities of BHA show that it has documented cytotoxicity and is implicated 
in triggering apoptosis through mitochondria-directed pathways. This cytotoxicity may 
trigger genotoxic effects that could contribute to carcinogenesis. Mitochondria can be 
driven to induce apoptosis in a myriad of ways. Loss of metabolic capacity or a sudden 
increase in membrane permeability causes the release of cytochrome c, signaling the 
cleavage of pro-caspases into active apoptotic caspase-3 (Budihardjo et al., 1999). BHA 
was shown to promote changes in mitochondrial membrane permeability and release of 
cytochrome c (Yu et al., 2000). The specific mechanism behind this effect, as well as 
other elements of BHA-induced cytotoxicity remain to be elucidated. 
 In order to identify the genes involved in the response to BHA, a genome-wide 
sensitivity assay has been performed in the Tang Lab. Among the more than 2,000 
deletion strains screened, this assay revealed that a deletion strain missing the gene 
encoding Dsk1 protein kinase shows a sensitive phenotype (data not published, Tang 
Lab). After a preliminary library of sensitive and resistant strains was established, a 
sorbitol-rescue assay was done to rule out potential osmotic stress. The scope of this 
assay was extremely wide, with over 5,000 strains screened (data not published, Tang 
Lab).  
 
SR protein-specific kinase Dsk1 and SR proteins 
 Dsk1 was discovered as a novel protein in fission yeast in 1993. Researchers 
studying the cold-sensitive gene dis1 found that multiple copies of a then-unknown gene 
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could suppress the dis1 phenotype. They named this novel protein dis1-suppressing 
protein kinase, or dsk1. Upon further characterization, it has been found that Dsk1 
phosphorylates serine/arginine residues, and can autophosphorylate both tyrosine and 
serine-arginine residues. Phosphorylation states and expression of Dsk1 change during 
the cell cycle (Takeuchi and Yanagida, 1993, Tang, et al., 2012). When Dsk1 is 
immunoprecipitated from mitotically blocked cell extracts, the phosphorylated form 
prevails. In contrast, in G1, S, or G2 phases, Dsk1 is not phosphorylated. Overexpression 
of Dsk1 using an nmt+ promoter causes cell elongation and delay of the G2/M 
checkpoint (Takeuchi and Yanagida, 1993). 
Further investigation of Dsk1 established it as a serine/arginine protein kinase 
(SRPK), and later as the yeast functional homolog of human SRPK1 (Tang et al., 1998, 
2000). The SRPK class of kinases specifically phosphorylates SR proteins, which are 
splicing factors essential for transcription-coupled splicing of pre-mRNA (Misteli and 
Spector, 1999). Among the characteristics shared by SR proteins are domains of 
alternating serine and arginine amino acid residues, known as RS domains. It has been 
established that both SRPKs and the similarly functioning LAMMER kinase family 
(human homologs are the Clk/Sty family) hyperphosphorylate the RS domains of SR 
proteins (Misteli et al., 1998). Phosphorylation of SR proteins by SRPKs and LAMMER 
kinases modulates their activity and subcellular localization (Colwill et al., 1996; Ghosh 
and Adams, 2011; Misteli, et al., 1998; Huang, et al., 2004). It is important to note that 
there is a significant amount of variation in function of SR proteins. Some act as exon 
enhancers, others as shuttling transcription factors. The shared RS domain of SR proteins 
allows SRPKs and LAMMER kinases to participate in regulation of each of these 
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functions, emphasizing their importance within the cell. Indeed, the viability of 
Δdsk1Δkic1 double deletion mutants is severely impaired (Tang et al., 2002). 
A significant theme in SR protein regulation is cellular localization. Changes in 
phosphorylation levels at the RS domain of SR proteins affect their subcellular 
localization, thus altering their distribution within the cell. In humans, 
hyperphosphorylated SR proteins bind to exon enhancing sequences along pre-mRNA, 
contributing to the decision making process of alternative splicing (Zahler et al., 1992; 
Kohtz et al., 1994; Montes et al., 2012). After splicing, dephosphorylation of SR proteins 
is associated with nuclear export of properly spliced mRNA sequences. Once exported 
from the nucleus, SR proteins are hyperphosphorylated once more and transported back 
to the nucleus (Figure 1). When in the nucleus, SR proteins localize to nuclear speckles, 
putative storage sites present during interphase (Spector et al., 1993) 
 
 
http://www.pnas.org/content/101/26/9666.full.pdf 
 
Figure 1. Schematic model of general SR protein function, showing phosphorylation 
dependent localization of SR proteins (Huang et al., 2004). 
 
Visualization of splicing factors including SR proteins has revealed that they 
aggregate into bright spots in the nucleus (Figure 2). These spots have since been termed 
“nuclear speckles.” Analysis of nuclear speckles using electron microscopy has shown 
that nuclear speckles consist of two types of structures: interchromatin granule clusters 
(IGCs) and perichromatin fibrils (PFs). Interchromatin granule clusters are approximately 
20-25 nm in diameter and are found in the interchromatin space within the nucleus. 
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Perichromatin fibrils often radiate from IGCs and can be found throughout the 
nucleoplasm (Sacco-Bubulya and Spector, 2002). Further investigation of these structures 
has revealed that PFs are the site of most active transcription in the nucleus, and that 
relatively little transcription occurs at IGCs (Misteli et al., 1998). SR proteins and other 
splicing factors are thought to aggregate in IGCs, forming the nuclear speckles seen using 
fluorescence microscopy. However, SR proteins must be shuttled from these sites to 
transcription sites in order to properly operate in pre-mRNA splicing (Caceres, et al., 
1997, Misteli et al., 1998).  
As has been stated above, it is clear that in both yeast and humans, localization of 
SR proteins to the nucleus requires Dsk1 and Kic1 (a LAMMER kinase), respectively 
(Figure 2; Misteli et al., 1998). It is now thought that once in the nucleus, SR proteins 
undergo another phosphorylation event that modulates their localization to nuclear 
speckles (Gui et al., 1994; Colwill et al., 1996; Misteli and Spector, 1997, 1999; Cazalla 
et al., 2002). This event is thought to alter the protein-protein interactions that allow SR 
proteins to aggregate into IGCs. More specifically, when SR proteins are 
hyperphosphorylated, they dissociate from IGCs, and when they are hypophosphorylated, 
they localize to IGCs (Sacco-Bubulya and Spector, 2002). Several lines of evidence 
support this conclusion. In humans, deletions in the RS domain of SR proteins prevent 
redistribution from nuclear speckles to sites of pre-mRNA (Misteli, et al., 1998). 
Additionally, overexpression of either SRPK or Clk/Sty causes loss of SR protein 
localization to speckles (Colwill, et al., 1996, Gui, et al., 1994, Sacco-Bubulya and 
Spector, 2002). Thus, SRPKs, LAMMER kinases are not only implicated in the 
regulation of SR protein translocation to the nucleus, but also in the shuttling of SR 
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proteins from IGCs to sites of active transcription. Taken together, these findings suggest 
that SRPKs and LAMMER kinases and their yeast homologs are involved in wide scale 
and fine-tuning of SR protein localization and function throughout the cell cycle.  
 
 
 
Figure 2. Localization of GFP tagged Srp2, a yeast SR protein, in either a wild type or 
Δdsk1 background. While localization to the nucleus is clear in the wild type strain (top), 
deletion of Dsk1 causes diffuse presence of Srp2 throughout the cell (Tang et al., 2007).  
 
SRPKs and LAMMER kinases are constitutively active, which suggests that their 
regulation depends on cellular localization patterns (Ghosh and Adams, 2011). In human 
models, SRPK1 is sequestered in the cytoplasm where it hyperphosphorylates newly 
synthesized SR proteins, allowing their entry into the nucleus. Upon recognition of 
certain signaling events, dependent on events such as stress, DNA damage, or 
progression of the cell cycle, SRPK1 translocates to the nucleus, where it can facilitate 
 10 
dissociation of SR proteins from speckles (Giannakouros et al., 2011). This seemingly 
binary subcellular regulation model is less clear in yeast, where in vivo studies using 
fluorescence microscopy show that Dsk1 tagged with GFP is present in both the nucleus 
and the cytoplasm, but shows stronger signals in the nucleus in all phases of the cell cycle 
(Tang, et al., 2012).   
 
Understanding Dsk1 deletion sensitivity to BHA 
 Data collected in the genome wide kinase deletion sensitivity assay has revealed 
that the Dsk1 deletion strain of yeast is sensitive to BHA exposure (data not published, 
Tang Lab). It is possible that fission yeast cells tolerate environmental exposure to BHA 
by altering gene expression patterns. Based on the close functional relationship between 
Dsk1 and mRNA processing, Dsk1 may be required for this reprogramming. Therefore, 
its absence may lead to increased sensitivity in the Dsk1 deletion strain. Additionally, 
because SRPKs are constitutively active and are subject to regulation through subcellular 
localization, changes in localization may be indicative of regulation of gene expression 
levels through Dsk1 sequestration. If this is the case, I hypothesize that treatment with 
BHA will lead to changes in cellular localization of Dsk1 in fission yeast cells.  
In order to test this hypothesis, a number of techniques were used. Fluorescence 
microscopy of a strain with a Dsk1-GFP fusion protein produced endogenously from its 
native promoter will show potential changes in localization within the nucleus. This 
method can start to address possible causes of Dsk1 deletion sensitivity to BHA. Because 
of conserved homology between Dsk1 and Srp1 and human SRPK1 and SRSF1, the 
results from these experiments extend beyond yeast. Although the findings stated here 
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cannot be directly applied to human biology, they offer a strong basis from which further 
research can expand.  
 
Materials and Methods 
Table 1. S. pombe strains used 
Strain Genotype Reference/source 
501 h- ade6-704 leu1-32 ura4-D18 Carr, University of Sussex 
ZT501Dsk1GFP h- ade6-704 leu1-32ura4-D18 dsk1-
GFP::kanMX6 
Tang, et al., 2012 
 
Yeast Cultures 
 Precultures of wild type 501 and ZT501Dsk1GFP were made by isolating a 
colony of each strain from a master plate and introducing it to a sterile culture tube 
containing 5 mL of yeast extract plus supplements (YES) (Table 1). All cultures were 
grown at 30 oC unless otherwise indicated. Precultures were left to grow overnight. The 
next day, the OD595 of the precultures was measured to determine cell density. Enough 
preculture was transferred to 15 mL of minimal media (MM) containing 225 mg/L each 
of adenine, histidine, uridine, and leucine to ensure a final cell concentration not higher 
than 2 x 107 cells/mL after 24 hours. This density is within log phase. At zero hours, each 
of these cultures was either treated with 0.4 mM BHA dissolved in 1% DMSO or with 
only 1% DMSO (control). The concentration of BHA used in these cultures corresponds 
to the IC70 of BHA. The generation times of the BHA treated and untreated cells were 5 
and 3.5 hours, respectively. 
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Fluorescence Microscopy  
At 5, 10, and 24 hours, approximately 1 x 107 cells from these cultures were 
harvested using a microcentrifuge. These cells were rinsed three times with sterile water 
by adding 1 mL water, vortexing, then spinning down the cells using a microcentrifuge, 
and removing the supernatant. After washing, the cells were resuspended in cold 70% 
ethanol to fix the cells. These samples were kept in the refrigerator until slides could be 
made. To make slides, fixed cells were rehydrated in 1 mL of sterile H2O and their 
concentration was checked using a light microscope to ensure that the cells were dense 
enough to be easily found under the microscope, but not so dense as to create multiple 
layers of cells on the slide. Five µL of this cell solution was pipetted onto a clean slide 
and allowed to evaporate over a hot plate on very low heat. Once evaporated, 5 µL of a 
9:1 solution of DAPI:calcofluor was added. This DAPI/calcofluor solution was made 
using the same protocol as in Tang, et al., 2012. A coverslip was placed over the solution 
and the slide was sealed using clear nail polish and kept refrigerated in the dark until 
observation. The cells were observed using an Olympus IX81 motorized inverted 
fluorescence microscope with magnification of 1000x and ImagePro Plus version 6.3 
(MediaCybernetics, Inc., Bethesda, MD, USA.) 
 
 
Results 
Cells treated with BHA show a series of morphological changes 
 Figure 3 shows changes in cell shape, size, and septation as a result of BHA 
treatment. Among the changes seen in BHA treated cells are elongation (Figure 3B, panel 
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iv), loss of rod shape (Figure 3B, panels ii and iii), and extremely thick, abnormal septa 
(Figure 3B, panel i). The very thick septa could be stained with calcofluor, but this did 
not happen all the time (data not shown). This may be because calcofluor stains new cell 
wall growth most efficiently and some of the wide septa were relatively old. Many 
treated cells also lost the rod shape that is characteristic of fission yeast cells, instead 
becoming circular, club-shaped, or globular.  
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Figure 3. Phase contrast microscopy shows a series of morphological changes in 
response to BHA. Cell size and shape of (A) Dsk1GFP cells treated with 1% DMSO 
(control) for 24 hours and (B) Dsk1GFP cells treated with 0.4 mM BHA for 24 hours. 
Original magnification 1000x, scale bar represents 10 µm. Black arrows represent cells 
showing altered features. 
 
 
 
 
 
 15 
Untreated Dsk1 has a diffuse cytoplasmic signal and a stronger nuclear localization 
signal 
 Fluorescence microscopy of dsk1GFP cells confirmed the previously established 
localization patterns of wild type Dsk1 in an untreated environment (Tang et al., 2012). 
Dsk1 is present throughout the cytoplasm but excluded from vacuoles (Figure 5). 
Furthermore, a markedly stronger GFP signal colocalizes with DAPI staining of DNA, 
showing that Dsk1 is present in higher quantities in the nucleus (Figure 4). With this 
localization pattern confirmed, changes in localization when dsk1GFP cells are treated 
with BHA can be compared to this control.  
 
 
 
Figure 4. Untreated dsk1GFP cells show a diffuse cytoplasmic localization pattern as 
well as distinct nuclear localization. Dsk1GFP cells were grown in MM + 1% DMSO 
(control) then fixed and observed using fluorescence microscopy (left panel) and 
DAPI/calcofluor (right panel). Merged images were generated by overlapping GFP and 
DAPI images. Original magnification 1000x, scale bar represents 10 µm. White arrows 
mark sites of nuclear localization. 
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BHA treated dsk1GFP shows reduced nuclear localization and the appearance of 
cytoplasmic clusters 
Figure 5 shows the localization of Dsk1 when S. pombe cells were treated with 
BHA compared to cells treated with 1% DMSO as a control. When exposed to BHA, two 
major observable changes in Dsk1 localization appear. The first is reduced nuclear 
localization. While in untreated cells, the dsk1GFP fusion protein has a clearly stronger 
GFP signal at nuclei, in BHA treated cells, the GFP signal is no stronger than its 
cytoplasmic background. Quantification of this phenotype reveals that the number of 
cells displaying reduced nuclear localization increases with time exposed to BHA. By 24 
hours, approximately 24.5% of cells showed poor Dsk1 localization to nuclei, which is 
more than 13 times that of untreated cultures (Figure 6A).  
 The second major phenotypic change observed in BHA treated cells was that 
Dsk1 appears to form cytoplasmic clusters that are often nowhere near the nucleus. Cells 
often showed multiple clusters per cell, as is seen in the 24-hour panels of BHA treated 
cells (Figure 5). Quantification of this phenotype showed a 2.5 fold increase in the 
percentage of cells displaying cytoplasmic Dsk1 clusters relative to control populations 
(Figure 6B).  
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Figure 5. Changes in the cellular localization of Dsk1 in BHA treated dsk1GFP cells. 
Dsk1GFP cells were grown for 5, 10, or 24 hours in MM + 0.4 mM BHA then fixed and 
observed using fluorescence microscopy for GFP (left panels) and DAPI/calcofluor 
(middle panels). Merged images were generated by overlapping GFP and DAPI images. 
Original magnification 1000x, scale bar represents 10 µm. White arrows mark sites of 
reduced nuclear localization in BHA treated dsk1GFP cells, red arrows mark Dsk1 
cytoplasmic clusters.  
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Figure 6. Quantitative analysis of changes in Dsk1GFP cellular localization induced 
by BHA. Phenotypes were quantified by calculating the percent of cells that displayed 
either reduced localization (A) or cytoplasmic clusters (B) in dsk1GFP cells treated with 
BHA after 5, 10, and 24 hours, as well as untreated control cells. At least 100 cells were 
counted for each treatment, data is combined from three separate trials. 
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Overall, it is clear that treatment with BHA causes morphological changes as well 
as changes in the localization of Dsk1 in S. pombe. Taken together, these results offer 
some novel observations of the effect of BHA on a fission yeast homolog of a major class 
of splicing factor regulators. That this is the case implies some functional relationship 
between Dsk1 and the cell’s overall response to BHA.   
 
 
Discussion 
Treatment of fission yeast cells with BHA leads to changes in overall morphology and 
increased vacuole abundance 
 One of the most easily observed changes in morphology in treated yeast was an 
increase in the abundance of vacuoles in each cell. This was especially obvious upon 
visualization with GFP, where the vacuoles could be seen as dark circular shapes with no 
GFP signal (Figure 5). In both fission yeast and budding yeast, vacuoles are used as a 
method of detoxification and their presence could indicate that the cell is attempting to 
sequester BHA from the rest of the cytoplasm to reduce its cytotoxic effects (Ortiz et al., 
1992). Additional morphology changes seen in fission yeast treated with BHA included 
both elongated and shortened phenotypes, loss of the characteristic rod shape, and very 
thick septa. These types of morphology changes indicate that BHA may affect more than 
one mechanism. Figure 7 shows how various cell cycle mutants lead to specific 
morphological changes in combination with BHA treatment. Each mutant represents 
what occurs when the functional protein is disrupted, demonstrating its role in 
maintaining proper morphological features. The simultaneous presence of many of these 
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phenotypes in populations of treated yeast emphasizes that BHA has strong, pleiotropic 
effects on cell populations.  
  
http://genesdev.cshlp.org/content/11/22/2939/F2.expansion.html 
 
Figure 7. Yeast mutations and resulting morphological changes. Yeast deletions and 
temperature sensitive mutations lead to the above morphological changes (Gould and 
Simanis, 1997). 
 
Reduced Dsk1 nuclear localization 
 In control populations of yeast, Dsk1 shows a strong cytoplasmic signal and a 
slightly stronger but clearly visible presence at nuclei (Figure 4). Such a localization 
pattern is well explained by data that shows that Dsk1 has functions in both the nucleus 
and the cytoplasm. Dsk1 present in the cytoplasm hyperphosphorylates SR proteins, 
causing them to be transported into the nucleus. Once in the nucleus, subsequent 
hyperphosphorylation events precipitate their dissociation from nuclear speckles so they 
can localize to sites of transcription and splicing (Sacco-Bubulya and Spector, 2002). 
However in BHA treated yeast, approximately 25% of the time Dsk1 nuclear 
accumulation like what is seen in untreated cells fails to occur. There are a number of 
potential consequences of reduced nuclear localization in fission yeast.  
As stated above, we know that hyperphosphorylation by SRPKs is necessary for 
SR proteins to delocalize from nuclear speckles and subsequently act in constitutive and 
alternative splicing (Sacco-Bubulya and Spector, 2002). If Dsk1 in BHA treated cells 
does not localize to nuclei with the same efficiency as untreated cells, it is possible that 
SR proteins are not hyperphosphorylated and released from speckles at normal rates. This 
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may cause changes in mRNA transcription, splicing, or export. The process that dictates 
exon inclusion is a finely tuned competition of both enhancing and silencing elements, 
and even a slight change in SR protein concentration or binding capacity due to changes 
in phosphorylation could strongly alter how pre-mRNA is spliced (Xiao and Manley, 
1997). Research on SRPKs in humans has illustrated that increased translocation of 
SRPKs to the nucleus alters splice site selection, thus the opposite, reduced nuclear 
localization, could do the same (Zhong et al., 2009). 
The result of this may ostensibly be the production of alternative gene products 
that act in a response pathway to BHA. Without Dsk1, a deletion strain would not be able 
to respond to BHA by altering Dsk1 subcellular localization. This may impair the ability 
of the cell to prompt SR proteins to alter gene expression patterns, preventing the creation 
of products that aid in the response to BHA, ultimately leading to the sensitive phenotype 
observed from the genomic screening assay. Such changes in expression patterns may 
also be responsible for generating the pleiotropic morphological effects seen in BHA 
treated yeast (Figure 3). 
Alternative splicing has essential functions in differentiation, development, and 
various stress responses, and is tissue specific (Stamm, 2002). If alternative splicing is 
significantly affected by BHA exposure, it may also explain why it causes the 
development of tumors in very specific tissue types even though it has been shown not to 
be directly mutagenic. Perhaps through activating specific alternative splicing events, 
BHA can trigger oncogenic mechanisms. To further investigate this possibility it is 
important to know whether or not the reduced nuclear localization of Dsk1 is 
significantly affecting hyperphosphorylation levels of SR proteins or their localization to 
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nuclear speckles. This knowledge would link the findings of this paper to the 
functionality of SR proteins and to mRNA processing and splicing. Additionally, an 
assay that compared levels of mRNA isoforms between BHA treated and control cells 
would shed further light onto the possibility that BHA acts through this mechanism.  
 BHA-treated yeast grow approximately 40% slower than control yeast treated 
with 1% DMSO (see methods). It is possible that if Dsk1 cannot localize efficiently to the 
nucleus to effect SR protein nuclear speckle dissociation, that mRNA production in 
general would be less efficient. Such inefficient mRNA processing has been shown to 
slow yeast growth (Pandit et al., 2009). Inhibition of pre-mRNA processing itself would 
interfere with the production of maintenance proteins necessary for cell growth. 
Furthermore, it has been shown that improperly spliced RNA is retained in the nucleus, 
offering another mechanism through which BHA could negatively affect the availability 
of necessary mRNA templates for protein synthesis (Fasken and Corbett, 2009).  
BHA results in Dsk1 cytoplasmic clusters 
Another major observation in treated populations was that Dsk1 appears to 
aggregate in cytoplasmic clusters upon treatment with BHA. In light of observations that 
suggest that SRPKs are often regulated by altering their presence within the cell, This 
phenomenon may be connected to reduced nuclear localization. Recent research in 
humans has shown that SRPK1 is anchored to specific heat shock chaperone proteins 
while in the cytoplasm, preventing them from translocating to the nucleus without 
specific types of signals (Zhong et al., 2009; Zhou et al., 2012). It is possible that the 
clusters seen in BHA treated cells are aggregations of Dsk1/chaperone complexes in the 
cytoplasm and that BHA is interrupting the signaling pathway necessary for Dsk1 to be 
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released from these complexes. The increased presence of such clusters over time in the 
treatment environment suggests support for this hypothesis; as such complexes seem to 
build up over time.  
In order to further address this possibility, we could observe the 
coimmunoprecipitants of Dsk1 from BHA-treated or control lysates. This would suggest 
that a similar mechanism occurs in yeast as does in humans, as well as provide support 
for the reasoning that chaperone interactions are causing the development of Dsk1 
clusters in BHA treated cultures.  
 
Concluding remarks 
 The results shown in this experiment demonstrate the strong, pleiotropic effects of 
BHA on wild type fission yeast expressing a Dsk1GFP fusion protein. Morphological 
changes such as increased vacuole formation are correlated with the presence of cytotoxic 
elements (Ortiz et al., 1992). More data is necessary to determine whether or not the 
increased incidence of vacuoles is a response to BHA cytotoxicity. Additionally, the 
observations collected throughout this research imply that BHA changes localization 
patterns of Dsk1. The reduction of Dsk1 presence within the nucleus, as well as the 
development of clusters of Dsk1 in the cytoplasm are evidence of this conclusion. The 
result of these changes may affect nuclear events in which Dsk1 is involved, namely, the 
regulation of mRNA splicing and processing factors. This may lead to a reprogramming 
of gene expression patterns, which would allow the cell to cope with environmental 
exposure to BHA. If alternative gene expression patterns must be activated in order to 
respond to BHA exposure, then regulation of Dsk1 activity through subcellular 
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sequestration to the cytoplasm rather than to the nucleus may reflect such an attempt to 
alter expression patterns. This model also highlights the importance of Dsk1 in 
responding to BHA, supporting unpublished data from the Tang Lab that a Dsk1 deletion 
strain is sensitive to BHA. 
Further investigation of the observed changes in cellular localization and their 
effect on the phosphorylation states and localization patterns of SR proteins is necessary 
to provide more evidence that Dsk1 acts in the response to BHA by altering gene 
expression through regulation of mRNA processing. Future experiments should attempt 
to observe whether or not BHA impedes the ability of Dsk1 to hyperphosphorylate SR 
proteins, as well as look at downstream events such as the effect of BHA on alternative 
splicing isoforms. Additionally, because of the close functional relationship between 
Dsk1 and Kic1, it would be interesting to make observations of the effect of BHA on 
Kic1 cellular localization using a Kic1GFP strain.   
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